Senior Technical Advisor, Pharmaceutical Policy and Governance
Management Sciences for Health (MSH)
May 9, 2018
Full Time - Experienced
4 Year Degree
This position will be the technical lead in Ukraine, with close support from HQs technical leads, in building the critical Essential Medicines List (EML) processes and institutionalization of Health Technology Assessment (HTA) and pharmacovigilance strengthening work, and providing health technical assistance on medicine pricing and reimbursement policies. S/he will support planning, implementation, and evaluation of SAFEMed activities related to medicines selection, quality, safety, effectiveness and rational medicines use, and the policies that support their implementation. S/he will be responsible for working with the government and stakeholders on pharmaceutical policy issues. S/he will develop positive working relationships with various domestic and international stakeholders working in Ukraine, including the Ministry of Health (MoH), SEC, civil society, and local and international manufacturers, and demonstrate a deep understanding of evolving processes in the Ukrainian pharmaceutical sector and organize program activities to achieve efficiencies in achieving programmatic targets.
This is a project based role and the project ends on September 2, 2022. This position is eligible for allowances and/or relocation.
Technical Assistance to promote accountability through pharmaceutical policies, regulations, guidelines, and standard operating procedures; institutionalizing pharmaceutical procedures and structures (60%)
Responsible for providing pharmaceutical policy and governance technical support to the Government of Ukraine (GoU), MoH, and EML Expert Committee to strengthen its institutional capacities in order to ensure the sustainability of the EML process. Ensure that effective, efficient, standardized, and transparent methods are implemented for HTA, management of the EML, with the support of the MoH and other stakeholders.
Provide legal and technical support to the MoH, Cabinet of Ministers, and other counterparts to enable transparent, effective and efficient selection, procurement, distribution, and use of medicines.
Provide legal and technical support to the MoH and Civil Society Organizations to establish a specialized mechanism for selection of medicines for reimbursing/procuring innovative and high cost drugs outside of the EML, working in close collaboration with key stakeholders.
Provide Technical Assistance to the MoH to advance legislation for the organizational development and sustainable funding of the HTA Agency.
Collaborate with SAFEMed senior staff on cross-cutting issues related to the pharmaceutical benefits program, supply chain management, and other issues.
Design and implement technical approaches, tools, workshops and advocacy events related to the promotion of medicine quality, safety and rational use.
Collaborate with partners and stakeholders (35%)
Provide information and increase understanding of HTA, and EML nationwide, for relevant stakeholders, including health professionals, government and NGO counterparts, patient advocacy organizations and other stakeholders.
Work with professional associations to develop policy options based on best practices that support evidence based decision-making for medicines selection and rational use.
Collaborate with the MoH, local partners, patient advocacy groups, and other stakeholders to ensure that they are fully engaged in processes to the extent possible.
Share information with stakeholders, including manufacturer associations and other key stakeholders at least on a quarterly basis to update on project activities and exchange ideas.
Contribute to the communications strategy for dissemination of information about process to increase support for health reforms in the area of pharmaceutical management.
Program Support (5%)
Participate with the Deputy Chief Of Party in the development of SAFEMed work plans and budgets as they relate to pharmaceutical policy and governance, and rational drug use activities. Provide input for updating and implementing the annual work plan and budget, as necessary.
Identify key areas in pharmaceutical policy and governance to highlight for technical reports, success stories, and/or operational research.
Take the lead in drafting documents, scopes of work, and contribute, as requested, to regular and ad hoc reporting to SAFEMed, USAID, the Ukrainian MoH or other relevant agencies.
REQUIRED MINIMUM EDUCATION:
Degree in medicine, pharmacy, pharmaco-economics or other public health related discipline.
Master’s level or above in medicine, pharmacy, public health, health policy or other related discipline.
Additional coursework or education in HTA, pharmaco-economics, rational use of medicines, or other related areas.
REQUIRED MINIMUM EXPERIENCE:
At least seven plus (7+) years progressively responsible experience in pharmaceutical related project management and/or public health.
Experience working with the MoH and national level organizations.
Experience and knowledge of the Ukraine health system and key actors within the system.
At least three (3) years relevant experience in regulatory affairs, essential medicines, EML or HTA, and in improving rational use and pharmaceutical services for HIV/AIDS, TB medicines, or other priority health conditions.
Experience working with USAID-funded programs is desirable.
KNOWLEDGE AND SKILLS:
Demonstrated ability to build and maintain relationships with senior-level colleagues, particularly interacting productively, proactively, and comfortably with government agencies, NGOs, private sector groups, USAID and other donor organizations.
Strong interpersonal, analytical, and advocacy skills.
Familiarity with public health, TB, and HIV/AIDS programming, data collection, analysis and presentation.
Ability provide trainings and make presentations to various groups, including high level government officials.
Demonstrated computer skills; knowledge of appropriate methods for data analysis and reporting.
Skills and knowledge to write cogent technical reports, documents and power points in English and Ukrainian.
Fluency in spoken and written Ukrainian or Russian desirable.
Spoken and written English not lower than upper intermediate required.
Functional competencies: Highly motivated, resourceful, and results driven. Able to gather and analyze information in order to make appropriate decisions. Strong skills in strategic thinking
Strong interpersonal and communication skills.
Ensuring delivery of results: Client focus, project management and measuring work, information sharing, priority setting, and problem solving.
Core personal competencies: Ethics and values, integrity and trust, listening, written communication; strong organizational skills and ability to work in a team oriented environment.
Core MSH competencies: Adaptability, communication, problem solving, creativity and innovation, timeliness of work, quality of work and team relationships, resource utilization.
Travel requirements: Availability to travel domestically and internationally as needed estimated at a level of 10-15% of time
Keyboard use, Pulling drawers,
Lifting papers <10lbs.
Internal Number: 13-9997
About Management Sciences for Health (MSH)
Management Sciences for Health (MSH), a global health nonprofit organization, uses proven approaches developed over 40 years to help leaders, health managers, and communities in developing nations build stronger health systems for greater health impact. We work to save lives by closing the gap between knowledge and action in public health. Since its founding in 1971, MSH has worked in over 150 countries with policy makers, health professionals, and health care consumers to improve the quality, availability and affordability of health services. Working with governments, donors, non governmental organizations, the private sector, and health agencies, MSH responds to priority health problems such as HIV & AIDS; tuberculosis; malaria; maternal, newborn and child health; family planning and reproductive health; and chronic non-communicable diseases such as cancer, diabetes, and lung and heart disease. Through strengthening capacity, investing in health systems innovation, building the evidence base, and advocating for sound public health policy, MSH is committed to making a lasting difference in global health.